Milestone Pharmaceuticals Inc.

MIST · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$12-$13-$21-$12
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$0$1
Change in WC-$0-$2$5$3
Other Non-Cash$2$1$2$1
Operating Cash Flow-$10-$13-$14-$7
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$36-$0-$1-$14
Inv. Sales/Matur.-$0$10$34$33
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$36$10$34$19
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$50$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$50$0$0$0
Forex Effect-$0$0$0$0
Net Chg. in Cash$4-$3$20$13
Supplemental Information
Beg. Cash$42$45$25$13
End Cash$47$42$45$25
Free Cash Flow-$10-$13-$14-$7